IMPLANET

Implanet is a French medical technology company specializing in orthopedic implants and surgical instruments for spinal pathologies. Founded in 2007 and headquartered near Bordeaux, the company develops innovative solutions for spine surgery with a focus on posterior fixation systems, anterior cervical cages, and intervertebral fusion devices. Its flagship JAZZ® platform includes the Jazz Spinal System™ and Squale™ anterior cervical cages, both FDA-approved. The product portfolio encompasses multiple fixation systems (Zeus™, Jazz™Evo, Jazz™Lock, Jazz™Claw, Jazz™PF, Saxxo™), intervertebral cages (Swingo™-T, Swingo™-P, Squale™), anterior cervical plates (Origin™), and surgical equipment including the Olea™ ultrasonic scalpel for endoscopic spine surgery. Implanet operates in 42 countries with a US subsidiary in Boston and is listed on the Euronext Growth market in Paris. The company collaborates with specialized spine surgeons and generated €12.5M in revenue in 2025.